期刊文献+

冠心病病变程度与BNP及超敏C-反应蛋白水平的相关性研究 被引量:4

下载PDF
导出
摘要 目的探讨冠心病(CHD)病变程度与脑型钠尿肽(BNP)及超敏C-反应蛋白水平(hs-CRP)的相关性。方法 100例CHD患者和同期32例健康者纳入研究,测定血浆BNP和hs-CRP含量,分析相关性。结果 AMI组、UAP组、SAP组和对照组的BNP和hs-CRP水平依次下降(P<0.05),同时BNP和hs-CRP水平随病变支数增多依次增大(P<0.05)。冠脉病变支数,冠脉病变积分,心功能级别与BNP和hs-CRP均呈正相关(P<0.05)。结论 BNP及hs-CRP与CHD有良好的相关性,可作为患者心脏功能、心肌缺血程度及危险分层的指标。
作者 刘子龙
出处 《河北医药》 CAS 2014年第14期2103-2104,共2页 Hebei Medical Journal
  • 相关文献

参考文献8

二级参考文献23

  • 1葛智平,陈晓春.C反应蛋白与不同类型冠心病相关性的临床研究[J].临床心血管病杂志,2005,21(2):78-80. 被引量:37
  • 2Wu MH,Wang JH,Lai CP,et al. Association of hs-CRP with the severity of coronary artery diasease and myocar- dial infarction[J]. Int J Cardiol, 2008,97 (Suppl 2): 47-49.
  • 3Taniguchi H, Momiyama Y, Ohmori R, et al. Associations of plasma greactive protein levels with the presence and extent of coronary stenosis in patients with stable coro-nary artery disease [J].Atherosclerosis, 2005, 178 (2): 173-177.
  • 4Suzuki T, Yamazaki T, Yazaki Y. The role of the natri- uretic peptide in the cardiovascular system[J].Cardiovasc Res,2001,51(2) :489-494.
  • 5Groenning B A, Nilsson J C, Sondergaard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions bymultiple neurohumoral plasma concentrations [J]. Eur J Heart Fail, 2001,3(6) :699-708.
  • 6Tao L, Gao E, Jiao X, et al. Adiponectin cardiopmteetion after myocardial ischemia-reperfusion involves the reduction of oxidative/nitrativestress[J]. Circulation, 2007,115 ( 11 ) : 1408- 1416.
  • 7De Silva R, Nikitin N P, Witte K K, et al. Incidence of renal dysfunction over 6 ITlonths in patients wi th chronic heart failure due to left ventrieular systolic dysfunction: contributing factors and relationship to Prognosis [J]. Eur Heart J, 2006,27(5) :569-581.
  • 8Yamada T, Node K, Mine T, et al. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study [J]. Am Heart J, 2007,153(6): 1055,e1-e8.
  • 9Arima H, Kubo M, Yonemoto K, et al. High sensitivity C- reactive protein and coronary heart disease in a general populationof Japanese:the Hisayama study [J]. Arterioscler Thromb Vasc Biol, 2008,28(7) : 1385-1391.
  • 10Ran TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty.A report of the American College of Cardiology American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures(Subcommitt ee on Percutaneous Transluminal Coronary Angioplasty).Cir culation, 1988, 78:486-502.

共引文献109

同被引文献54

  • 1Libby P, Riker PM, Maseri A. Inflammation and atherscle- rosis circulation [J]. Circulation, 2002,105(9) :1135-1143.
  • 2Crea F, Biasucci LM, Buffon A, et al. Role of inflammation in the pathogenesis of unstable coronary artery disease [J]. Am J Cardiol,2003,80(5A) : 10-16.
  • 3Muller K,Aichele S,Herkommer M,et al. Impact of in- flammatory markers on platelet inhibition and cardiovas- cular outcome including stent thrombosis in patients will symptomatic cornonary artery disease [J]. Atherosclerosis, 2010,213(1) :256-262.
  • 4Harris TB, Ferrucci L,Tilacy RP, et al. Associations of el- evated interleukin-6 and C-reactive protein levels in old age [J]. AM J Med, 1999,106(5):506-512.
  • 5White HD, French JK. Use of brain natriuretic peptide levels of risk assessment in non-ST-elevation acute coronary syndromes [J]. Am Coll Cardiol,2003,42 (11): 1917-1920.
  • 6SCHLETY C L,NANCE J ,SCHOEPF U J,et al. Differences in coro- nary artery disease by CT angiography between patients developing unstable angina pectoris vs. major adverse cardiac events [ J ]. Eur J Radiol,2014,83 (7) :1113-1119.
  • 7VILA-FRANCES J, SANCHIS J, SORIA-OLIVAS E, et al. Expert system for predicting unstable angina based on Bayesian networks [ J]. Expert Syst App1,2013,40(12) :5004-5010.
  • 8CHEGWIN-ANGARITA C,NIETO-RAMIREZ N I, GJ D, et al. Eval- uation of a method using high performance liquid chromatography with ultraviolet detection for the determination of statins in macromy-cetes of the genus pleurotus cultivated by fermentation processes [ J ]. Talanta,2013,15 (116) :56-64.
  • 9ICONOMIDOU V A,PHEIDA D, HAMODRAKA E S,et al. An amy- loidogenic determinant in N-terminal pro-brain natriuretic peptide (NT-proBNP) : Implications for cardiac amyloidoses [ J 1. Biopoly- mers,2012,98( 1 ) :67-75.
  • 10杨志娟.冠心病患者血清IL-6和IL-10水平检测的临床意义[J].内科,2009,4(4):552-553. 被引量:6

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部